Sanofi Consumer Healthcare India Ltd (SANOFICONR) is currently trading at 3,430.60 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Sanofi Consumer Healthcare India Limited is a standalone fast‑moving consumer healthcare (FMCH) company formed by demerging Sanofi India’s Consumer Healthcare division, operating established OTC brands and relaunch programs while leveraging Opella/Global R&D and technology to serve the Indian self‑care market as an India‑first innovation hub. The company reported revenue from operations of ₹8,784 million in FY2025 and posted strong operational recovery with reported year‑over‑year growth of +21% in revenue, a +13% increase in operating profit, and a +33% rise in profit after tax versus FY2024, demonstrating rapid improvement after earlier disruption. A period of turbulence following voluntary recalls and organizational separation was followed by focused relaunches (DePURA, Combiflam suspension, Allegra variants) and structural moves such as inventory transfer and last‑mile supply chain separation, indicating management has prioritized brand restoration and distribution realignment to reignite demand. Strategically the company emphasizes a digital‑first FMCH model that combines HCP initiation and self‑choice, substantial planned A&P investment in the mid‑teens, a dedicated in‑house AI creative team, and a multimedia reach target of ~60 million, signaling significant marketing intensity to capture the growing self‑care opportunity.

Over the past 52 weeks, Sanofi Consumer Healthcare India Ltd has traded between a low of ₹3,168.85 and a high of ₹5,241.35. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Sanofi Consumer Healthcare India Ltd has a market capitalization of approximately 7,986.90. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Sanofi Consumer Healthcare India Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 28.56 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 7,986.90 Cr, Sanofi Consumer Healthcare India Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Sanofi Consumer Healthcare India Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Sanofi Consumer Healthcare India Ltd is 28.56. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Revenue from operations was Rs 2,292 million and net profit was Rs 678 million in Q1CY26.

The quarterly table shows Total Revenue of ₹220.90 crore for the quarter ended Jun 25, compared with ₹229.20 crore in Mar 26 and ₹164.40 crore in Jun 24.